TH Open
(Jan 2024)
Risk Profiles and Treatment Patterns in Atrial Fibrillation Patients with Chronic Kidney Disease Receiving or not Receiving Anticoagulation Therapy
Reinhold Kreutz,
Gilbert Deray,
Jürgen Floege,
Marianne Gwechenberger,
Kai Hahn,
Andreas R. Luft,
Pontus Persson,
Christoph Axthelm,
Juerg Hans Beer,
Jutta Bergler-Klein,
Nicolas Lellouche,
Jens Taggeselle,
Jan Beyer-Westendorf
Affiliations
Reinhold Kreutz
ORCiD
Institute of Clinical Pharmacology and Toxicology, Charité – Universitätsmedizin Berlin, Berlin, Germany
Gilbert Deray
Department of Nephrology, Pitié-Salpêtrière Hospital, Paris 6 University, Paris, France
Jürgen Floege
Division of Nephrology and Clinical Immunology, RWTH Aachen University Hospital, Aachen, Germany
Marianne Gwechenberger
Division of Cardiology, University Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
Kai Hahn
Nephrologische Praxis, Dortmund, Germany
Andreas R. Luft
Center for Neurology and Rehabilitation, Klinik für Neurologie, Universitätsspital Zürich, Switzerland and Cereneo, Vitznau, Switzerland
Pontus Persson
Institut für Vegetative Physiologie, Charité – Universitätsmedizin Berlin, Berlin, Germany
Christoph Axthelm
Cardiologicum Pirna and Dresden, Dresden, Germany
Juerg Hans Beer
Department Innere Medizin, Baden Switzerland and Center of Molecular Cardiology, Kantonsspital Baden, University of Zürich, Zürich, Switzerland
Jutta Bergler-Klein
Division of Cardiology, University Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
Nicolas Lellouche
Service de Cardiologie 1, Centre Hospitalier Universitaire Henri Mondor, Créteil, France
Jens Taggeselle
Praxis Dr. med. Jens Taggeselle, Markkleeberg, Germany
Jan Beyer-Westendorf
Thrombosis Research Unit, Division Haematology, Department of Medicine I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
DOI
https://doi.org/10.1055/s-0044-1780529
Journal volume & issue
Vol. 08,
no. 01
pp.
e106
– e113
Abstract
Read online
Background Patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are at high risk for both thromboembolism and bleeding events. The latter induces a potential reason for withholding oral anticoagulation (OAC) despite an indication for prophylaxis of thromboembolic events.
Keywords
Published in TH Open
ISSN
2512-9465 (Online)
Publisher
Georg Thieme Verlag KG
Country of publisher
Germany
LCC subjects
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website
https://doi.org/10.1055/s-00033990
About the journal
WeChat QR code
Close